The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.
The invention relates to compounds of Formula (I). Compounds of the present invention are inhibitors of sphingosine kinase 3, and are useful in the treatment of various disorders and conditions, such as inflammatory disorders.
Discovery of novel sphingosine kinase 1 inhibitors
作者:Yibin Xiang、Gary Asmussen、Michael Booker、Bradford Hirth、John L. Kane、Junkai Liao、Kevin D. Noson、Christopher Yee
DOI:10.1016/j.bmcl.2009.09.022
日期:2009.11
Sphingosine kinase 1 (SK1) is an important enzyme that regulates the balance between ceramide and sphingosine-1-phosphate (S1P). Potent and novel SK1 inhibitors (6ag, 9ab and 12aa) have been discovered through a series of modi. cations of sphingosine ( 1), the substrate of this enzyme. (c) 2009 Elsevier Ltd. All rights reserved.
(EN) The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.(FR) L'invention concerne de nouveaux composés représentés par la formule (I) qui présentent une activité agoniste au niveau des récepteurs de la sphingosine-1-phosphate (S1P), leur processus de préparation et leur utilisation en tant qu'agents immunosuppresseurs.
[EN] INHIBITORS OF SPHINGOSINE KINASE 1<br/>[FR] INHIBITEURS DE LA SPHINGOSINE KINASE 1
申请人:GENZYME CORP
公开号:WO2010033701A2
公开(公告)日:2010-03-25
The invention relates to compounds of Formula (I). Compounds of the present invention are inhibitors of sphingosine kinase 3, and are useful in the treatment of various disorders and conditions, such as inflammatory disorders.